The biotech veteran tasked with saving Biogen; doctors turn to an alternative for recertification

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: For the 'godfather' of biotech, saving Biogen is the final act of a singular career By Damian Garde Mike Reddy for STAT Stelios Papadopoulos, at the summit of a career spanning most of biotech’s recorded history, faces a challenge that will color his legacy. Read More STAT+: Fed up with costly, onerous recertification, doctors are turning to an alternative board By Tara Bannow Adobe Fed up with the costly, onerous process of recertification, doctors are increaasingly turning to an alternative board. Read More Opinion: Amazon and One Medical: Minding the data gaps By Alexander Chaitoff and Khin-Kyemon Aung and Alexander Zheutlin One Medical The neighborhoods with One Medical clinics don't look anything like average U.S. neighborhoods. That could be a key data gap for Amazon. Read More Sponsor content by STAT Leading JAMA Through Turmoil New JAMA editor-in-chief, health equity advocate Kirsten Bibbins-Domingo, takes the virtual stage on September 20. She'll share how she plans to steer the prestigious publication through recent turbulence and chart a new journey forward. Join the conversation. An ambitious stroke prevention study tests the Apple Watch's promise in health By Mario Aguilar Adobe A new study will investigate whether Apple Watches can help minimize unnecessary use of blood thinners in patients with A-fib. Read More Monday, August 29, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser